文献速递冠心病

中性粒细胞来源的S100A8/A9放大心肌梗死后粒细胞生成

Neutrophil-Derived S100A8/A9 Amplify Granulopoiesis After Myocardial Infarction.
PubMed 文献 · Circulation · 2020-01-16

该研究在小鼠心肌梗死模型中发现,中性粒细胞释放的警报素S100A8/A9通过TLR4和NLRP3炎症小体促进IL-1β分泌,进而刺激骨髓造血干细胞和祖细胞的粒细胞生成;遗传或药物阻断该通路可抑制粒细胞生成并改善心功能。在急性冠脉综合征患者中,入院时和血运重建后中性粒细胞计数升高与主要不良心血管事件正相关。

要点

  • 心肌梗死后中性粒细胞释放S100A8/A9,激活TLR4-NLRP3-IL-1β轴促进粒细胞生成。
  • 阻断S100A8/A9或其下游信号可抑制粒细胞生成并改善小鼠心功能。
  • 急性冠脉综合征患者中性粒细胞计数升高与主要不良心血管事件正相关。

核心结论

  • 中性粒细胞来源的S100A8/A9是心肌梗死后炎症反应和粒细胞生成的关键驱动因素。
  • 靶向S100A8/A9及其下游介质可能改善急性冠脉综合征患者的心功能。

研究设计与样本

  • 采用小鼠左前降支永久结扎心肌梗死模型,结合流式细胞术和全局转录组分析。
  • 使用遗传和药理策略验证信号通路,并通过超声心动图评估心功能。
  • 在急性心肌梗死患者队列中分析早期中性粒细胞增多与主要不良心血管事件的关联。

主要发现

  • 心肌梗死后中性粒细胞快速募集至梗死区并释放S100A8和S100A9。
  • S100A8/A9结合TLR4并激活NLRP3炎症小体,促进IL-1β分泌。
  • IL-1β作用于骨髓造血干细胞和祖细胞的IL-1R1,以细胞自主方式刺激粒细胞生成。
  • 遗传或药理阻断S100A8/A9及其下游信号可抑制粒细胞生成并改善心功能。
  • 急性冠脉综合征患者入院时和血运重建后中性粒细胞计数升高与主要不良心血管事件正相关。

临床怎么用

  • 监测急性冠脉综合征患者中性粒细胞计数可能有助于风险评估。
  • S100A8/A9及其下游信号通路是潜在的治疗靶点,但需进一步临床验证。

局限性

  • 主要机制证据来自小鼠模型,人体中的因果作用尚未确定。
  • 患者队列仅显示关联性,不能证明因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Myocardial infarction (MI) triggers myelopoiesis, resulting in heightened production of neutrophils. However, the mechanisms that sustain their production and recruitment to the injured heart are unclear. METHODS: Using a mouse model of the permanent ligation of the left anterior descending artery and flow cytometry, we first characterized the temporal and spatial effects of MI on different myeloid cell types. We next performed global transcriptome analysis of different cardiac cell types within the infarct to identify the drivers of the acute inflammatory response and the underlying signaling pathways. Using a combination of genetic and pharmacological strategies, we identified the sequelae of events that led to MI-induced myelopoiesis. Cardiac function was assessed by echocardiography. The association of early indexes of neutrophilia with major adverse cardiovascular events was studied in a cohort of patients with acute MI. RESULTS: Induction of MI results in rapid recruitment of neutrophils to the infarct, where they release specific alarmins, S100A8 and S100A9. These alarmins bind to the Toll-like receptor 4 and prime the nod-like receptor family pyrin domain-containing 3 inflammasome in naïve neutrophils and promote interleukin-1β secretion. The released interleukin-1β interacts with its receptor (interleukin 1 receptor type 1) on hematopoietic stem and progenitor cells in the bone marrow and stimulates granulopoiesis in a cell-autonomous manner. Genetic or pharmacological strategies aimed at disruption of S100A8/A9 and their downstream signaling cascade suppress MI-induced granulopoiesis and improve cardiac function. Furthermore, in patients with acute coronary syndrome, higher neutrophil count on admission and after revascularization correlates positively with major adverse cardiovascular disease outcomes. CONCLUSIONS: Our study provides novel evidence for the primary role of neutrophil-derived alarmins (S100A8/A9) in dictating the nature of the ensuing inflammatory response after myocardial injury. Therapeutic strategies aimed at disruption of S100A8/A9 signaling or their downstream mediators (eg, nod-like receptor family pyrin domain-containing 3 inflammasome, interleukin-1β) in neutrophils suppress granulopoiesis and may improve cardiac function in patients with acute coronary syndrome.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Sreejit G, Abdel-Latif A, Athmanathan B, et al. Neutrophil-Derived S100A8/A9 Amplify Granulopoiesis After Myocardial Infarction. Circulation. 2020. PMID: 31941367. doi:10.1161/CIRCULATIONAHA.119.043833

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。